TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 51 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,128,000 | -69.7% | 10,000,000 | -69.7% | 0.17% | -70.7% |
| Q2 2019 | $30,103,000 | -51.2% | 32,959,000 | -50.4% | 0.58% | -57.2% |
| Q1 2019 | $61,718,000 | +1.7% | 66,506,000 | -0.8% | 1.36% | -7.3% |
| Q4 2018 | $60,698,000 | -7.5% | 67,030,000 | -4.1% | 1.47% | +8.6% |
| Q3 2018 | $65,625,000 | +156.2% | 69,885,000 | +153.1% | 1.35% | +150.8% |
| Q2 2018 | $25,611,000 | +104.5% | 27,608,000 | +95.7% | 0.54% | +119.1% |
| Q1 2018 | $12,526,000 | +56.7% | 14,105,000 | +56.6% | 0.25% | +60.8% |
| Q4 2017 | $7,992,000 | -46.0% | 9,005,000 | -45.0% | 0.15% | -45.4% |
| Q3 2017 | $14,795,000 | -58.0% | 16,371,000 | -50.0% | 0.28% | -58.4% |
| Q2 2017 | $35,196,000 | -7.6% | 32,751,000 | -7.8% | 0.67% | -5.5% |
| Q1 2017 | $38,080,000 | +1.1% | 35,520,000 | +3.1% | 0.71% | +2.6% |
| Q4 2016 | $37,673,000 | -4.4% | 34,466,000 | +4.4% | 0.69% | +21.8% |
| Q3 2016 | $39,393,000 | -7.8% | 33,022,000 | -2.9% | 0.57% | -13.8% |
| Q2 2016 | $42,711,000 | +47.7% | 34,021,000 | +53.0% | 0.66% | +49.5% |
| Q1 2016 | $28,926,000 | +25.7% | 22,243,000 | +52.9% | 0.44% | +24.9% |
| Q4 2015 | $23,021,000 | +75.4% | 14,543,000 | +50.8% | 0.35% | +76.1% |
| Q3 2015 | $13,128,000 | +37.1% | 9,643,000 | +40.9% | 0.20% | +45.7% |
| Q2 2015 | $9,576,000 | -57.0% | 6,843,000 | -54.4% | 0.14% | -57.1% |
| Q1 2015 | $22,283,000 | +174.3% | 15,002,000 | +153.1% | 0.32% | +170.6% |
| Q4 2014 | $8,124,000 | +80.9% | 5,927,000 | +69.3% | 0.12% | +72.5% |
| Q3 2014 | $4,491,000 | +1.9% | 3,500,000 | 0.0% | 0.07% | +4.5% |
| Q2 2014 | $4,407,000 | +127.6% | 3,500,000 | +133.3% | 0.07% | +120.0% |
| Q1 2014 | $1,936,000 | -48.2% | 1,500,000 | -57.1% | 0.03% | -36.2% |
| Q4 2013 | $3,734,000 | +194.0% | 3,500,000 | +189.0% | 0.05% | +135.0% |
| Q2 2013 | $1,270,000 | – | 1,211,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 95,823,000 | $114,365,000 | 5.28% |
| INCOME RESEARCH & MANAGEMENT | 12,056,000 | $14,384,000 | 2.34% |
| AEGON USA Investment Management, LLC | 6,000,000 | $7,159,000 | 1.44% |
| MACKAY SHIELDS LLC | 18,832,000 | $22,547,000 | 1.02% |
| CSS LLC/IL | 14,850,000 | $17,728,000 | 0.86% |
| SHENKMAN CAPITAL MANAGEMENT INC | 8,492,000 | $10,174,000 | 0.78% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,022,000 | $39,393,000 | 0.57% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,088,000 | $7,254,000 | 0.26% |
| AXA S.A. | 34,000,000 | $40,566,000 | 0.18% |
| SSI INVESTMENT MANAGEMENT LLC | 1,664,000 | $1,975,000 | 0.18% |